Epac1-deficient mice have bleeding phenotype and thrombocytes with decreased GPIbβ expression

Area of Science:

• Molecular Biology
• Hematology
• Physiology

Background:

• Exchange protein directly activated by cAMP 1 (Epac1) is known to regulate endothelial barrier function and limit fluid loss.
• Its role in hemostasis, particularly in restraining bleeding, has not been fully elucidated.

Purpose of the Study:

• To investigate the role of Epac1 in hemostasis and bleeding.
• To determine the impact of Epac1 deficiency on platelet function and blood coagulation.

Main Methods:

• Utilized Epac1 knockout (Epac1-/-) mice and compared them to wild-type mice.
• Performed quantitative proteomics to analyze platelet composition.
• Assessed in vitro secondary hemostasis and viscoelastic clotting function.
• Measured plasma coagulation factor levels and platelet characteristics.

Main Results:

• Epac1-/- mice exhibited prolonged bleeding times and deficient secondary hemostasis.
• Proteomics revealed unbalanced expression of the glycoprotein Ib-IX-V (GPIb-IX-V) complex in Epac1-/- platelets, with decreased GP1bβ.
• Epac1-/- mice showed reduced plasma coagulation factors (including Factor XIII and fibrinogen), increased platelet size, and higher reticulated platelet counts.

Conclusions:

• Epac1 plays a critical role in hemostasis by regulating platelet function and blood clotting.
• Deficient Epac1 activity during megakaryopoiesis and thrombopoiesis likely leads to the observed platelet phenotype and coagulation defects.
• Epac1 is essential for proper secondary hemostasis.